Meanwhile, India enters the list of top 5 infected nations; European airlines set to resume operations
From five lessons India should learn from the crisis, to state of sport post-Covid, read these and more in today's India dispatch
Since the beginning of the pandemic, surprisingly, the WHO had refused to endorse masks
AstraZeneca deal with SII is for supply of a billion doses, with a commitment to provide 400 mn before 2020-end. If all goes well, India could have its first set of Covid-19 vaccines by end of year
Gavi's routine immunisation efforts, including during the course of the coronavirus pandemic, help stop the spread of infectious diseases and the resurgence of other epidemics
While the mortality rate seems to be plateauing in UK , Spain and Italy after peaking, in India he bad news is that it hasn't reached the high point after which it can start tapering off
Govt will take inter-departmental approach to ensure right vaccine candidate is available for Indians at the earliest
The vaccine completed standard pre-clinical studies, and an optimum immune response was elicited by the adjuvant vaccine in phase-1 trials in India
He expressed satisfaction on the progress of the research connected with the vaccine development so far, but insisted that "in science, things can change"
At day 11, around 76% of the patients in the 5-day treatment group showed improvement in clinical status versus 66% for standard care alone, Gilead said
The WHO issued a "Solidarity Call to Action", asking other stakeholders to join the voluntary push.
The quickest for any vaccine to be prepared is not less than four years, says Kiran Mazumdar-Shaw.
At present there are three clinical trials underway to test nafamostat in Covid19 patients around the world
ICMR conducting study on presence of antibodies in people, results next week
The British drugmaker is working on its own COVID vaccine with Sanofi
The University of Oxford last week announced that the advance human trial of the vaccine will involve up to 10,260 volunteers across the UK
There are over 100 candidate vaccines which are at different levels of development
The problem of slipping vaccine rates is not limited to developing countries
Active cases rose to 69,597, while 51,783 people have recovered and a patient has migrated, according to the ministry bulletin
The early-stage trial, published in the Lancet, was conducted by researchers at several laboratories and included 108 participants aged 18 to 60